Cohort Study of Long-term Safety of Upadacitinib for the Treatment of Ulcerative Colitis and Crohn’s Disease in a Real-world Setting in Europe

Documents

Study protocol

Initial protocol

p24343-protocol-pmos-v1.0_Redacted 2.pdf

Study results

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

This study has been awarded the ENCePP seal

Conflicts of interest of investigators

DeclarationofInterests-Annex5-JReutfors

Composition of steering group and observers

EUPAS107124-107878

Signed code of conduct

ENCePP Declaration of compliance_signed.pdf

Signed code of conduct checklist

ENCePP Checklist Code of conduct_signed.pdf

Signed checklist for study protocols

Signed ENCePP checklist for Upa IBD PASS v1.0 Study Protocol.pdf